Amy Marcen-Gaudaur

Represented Allied Properties Real Estate Investment Trust, a leading owner-operator of distinctive urban workspace in Canada’s major cities, in the acquisition from Westbank of a 90% ownership interest in 400 West Georgia Street in Vancouver, and an additional 45% ownership interest in 19 Duncan Street in Toronto (increasing Allied’s ownership interest to 95%). The transaction was based on an aggregate property value of $920.7 million.

Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of its US$8.25-million overnight marketed public offering of units.

Represented Cybin Inc., a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of a US$30 million common share purchase agreement.

Represented Aleafia Health Inc., a vertically integrated and federally licensed Canadian cannabis company, in connection with the closing of its amendment of its $37-million convertible debentures and a private placement of units. 

Acted as Ontario and Quebec counsel to Gillfor Distribution Inc. in connection with the acquisition and financing of AFA Forest Products Inc., a leading and long-standing distributor for building products in Canada.

Represented Allied Properties Real Estate Investment Trust, a leading operator of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its acquisition of six urban office properties from Choice Properties Real Estate Investment Trust for $794 million.

Represented Harborside Inc. (CSE: HBOR) (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, in its acquisitions of Loudpack and Urbn Leaf.

Represented Nextleaf Solutions Ltd., a federally regulated producer of cannabis oil that distributes cannabis vapes and oils under its prohibition-era brand, Glacial Gold^TM, in the completion of a marketed public offering of units.

Represented Baylin Technologies Inc. (TSX:BYL), a leading, diversified, global technology company, in its completion of a private placement offering of 17,648,000 common shares at a price of $0.85 per common share for aggregate gross proceeds of approximately $15 million.

Represented Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its completion of a $500 million debt offering of 3.095% series I senior unsecured debentures. The Series I Debentures are Allied’s second Green Bond issuance under its previously announced Green Financing Framework.

Advised Melchior Management 777 Corporation in the formation of a new private residential REIT consisting of 38 multi-family properties totalling 1,260 residential units located throughout southern Ontario.

Advised MediPharm Labs Corp., a leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in the completion of a $33 million bought deal offering.

Represented PsyBio Therapeutics, Inc., a biotechnology company developing a new class of drugs intended for the potential treatment of mental health challenges and other disorders, in the completion of its reverse takeover of PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) and related private placement offering of subscription receipts for aggregate gross proceeds of $14.5 million.

Represented Harborside Inc., a California-focused, vertically-integrated cannabis enterprise, in the completion of a brokered private placement offering of units for aggregate gross proceeds of approximately $35 million.

Represented Allied Properties Real Estate Investment Trust in its completion of a $600 million debt offering of 1.726% series H senior unsecured debentures. The Series H Debentures are Allied’s inaugural Green Bond issuance under its recently announced Green Financing Framework.

Represented Baylin Technologies Inc. (TSX:BYL), a leading, diversified, global technology company, in its completion of a private placement offering of 6,666,700 units at a price of $0.75 per unit.

Represented Feronia Inc. (TSXV: FRN), an agribusiness operating in the Democratic Republic of the Congo, in connection with the completion of a third party sale and restructuring transaction, resulting in the sale of substantially all of the Company’s assets, including its direct and indirect equity interests in its operating subsidiary, Plantations et Huileries du Congo.

Represented MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in its completion of a $37.8 million private placement with an institutional investor.

Represented Allied Properties Real Estate Investment Trust in its completion of a $300 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $400 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $345 million public equity offering of units.

Represented Harborside Inc. (formerly Lineage Grow Company Ltd.) (CSE: HBOR) in the completion of its reverse takeover of FLRish, Inc. pursuant to the terms of a merger agreement among the Company, FLRish and Lineage Merger Sub Inc. by way of a “three-cornered merger.”

Represented Pistil Partners Inc. in the completion of a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.

Represented Allied Properties Real Estate Investment Trust in its completion of a $300 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $345 million public equity offering.

Advised MediPharm Labs Inc., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, in the completion of a $75 million bought deal offering.

Represented Feronia Inc. in connection with its recent US$19.3 million private placement of common shares issued to existing shareholders Straight KKM 2 Limited, CDC Group plc and Golden Oil Holdings Limited.

Represented Allied Properties Real Estate Investment Trust in its completion of a $230 million public equity offering.

Advised MediPharm Labs Corp. in a reverse take-over of the company. The shares of MediPharm Labs trade on the TSXV under the ticker symbol “LABS”.

Represented Allied Properties Real Estate Investment Trust in its completion of a $155 million public equity offering.

Advised MediPharm Labs Inc., a licensed Canadian cannabis manufacturer specializing in the pharmaceutical production of oil products, on a $22.3 million private placement.

Represented Baylin Technologies Inc. in the completion of a $40.25 million bought deal public offering of subscription receipts and 6.5% extendible convertible unsecured debentures and the related acquisition of Alga Microwave Inc.

Represented Allied Properties Real Estate Investment Trust in its completion of a $299 million public equity offering.

Represented Skyline Enterprises Management Inc. in the formation of Skyline Mortgage Investment Trust and the private placement offering of units for gross proceeds of up to $13 million.

Represented Baylin Technologies Inc. in an acquisition of assets from the radio frequency and microwave divisions of Advantech Wireless Inc. and certain of its affiliates. 

Represented Spectra7 Microsystems Inc. (TSX:SEV), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, in a $15.3 million bought deal public offering.

Represented Baylin Technologies Inc. in a $19.8 million bought deal public offering.

Represented a purchaser in the acquisition of a privately-held regional lumber company. The transaction involved the simultaneous closing of a large credit facility with a major Canadian bank, which included a term loan and an asset based revolving credit facility. 

Represented a family office in the acquisition of a North American furniture and cabinet design and manufacturing company. The target corporation had operations in Ontario, Illinois, Indiana and North Carolina. The purchase involved the simultaneous closing of a credit facility with a major Canadian bank, which included a term loan and multiple asset based revolving credit facilities.

"How to ‘B’ a Socially and Environmentally Conscious Business: B Corp Certification for Canadian Corporations," co-authored with Hannah Downard, ESG Bulletin, April 2024.

"CSA Provides Updated Guidance on Virtual Shareholder Meetings," co-authored with Shaun Pretli, Capital Markets Bulletin, March 2024.

"Progress in Standardizing Voluntary ESG and Sustainability Reporting," co-authored with Melanie Cole, Nadia S. Narain and Alyssa Marchese, Capital Markets Bulletin, September 2023.

"ESG and Capital Raising: An Overview of the Unique Sustainable Finance Tools Available to Canadian Businesses," co-authored with Melanie Cole and Karlie Nordstrom, Capital Markets Bulletin, May 2023.

"Rethinking Diversity in Canada’s Capital Markets: Beyond Gender," co-authored with Melanie Cole and Meredith McCann, Capital Markets Bulletin, November 2021.

• Osgoode Certificate in Mining Law, Osgoode Hall Law School, 2023
• Certificate in Canadian Securities Law and Practice, Osgoode Hall Law School, 2019
• JD, The University of Western Ontario, 2016
• BA, The University of Western Ontario, 2011